David Matthew Stark Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

David Matthew Stark is Exec. VP Chief Legal Officer of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 2,974 shares of TEVA, which is worth approximately $53,413. The most recent transaction as insider was on Mar 07, 2023, when has been sold 49,475 shares (Ordinary Shares) at a price of $9.43 per share, resulting in proceeds of $466,549. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.97K

0% 3M change

0% 12M change

Total Value Held $53,413

David Matthew Stark Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2023	SELL Open market or private sale	$466,549 $9.43 p/Share	49,475 Reduced 94.33%	2,974 Ordinary Shares
Mar 06 2023	SELL Open market or private sale	$163,755 $9.93 p/Share	16,491 Reduced 23.92%	52,449 Ordinary Shares
Mar 05 2023	BUY Exercise of conversion of derivative security	-	20,199 Added 22.66%	68,940 Ordinary Shares
Mar 04 2023	BUY Exercise of conversion of derivative security	-	45,767 Added 48.43%	48,741 Ordinary Shares
Feb 28 2023	SELL Open market or private sale	$626,857 $9.89 p/Share	63,383 Reduced 95.52%	2,974 Ordinary Shares
Feb 28 2023	BUY Exercise of conversion of derivative security	-	63,383 Added 56.94%	47,927 Ordinary Shares
Jul 28 2022	SELL Open market or private sale	$525,794 $9.04 p/Share	58,163 Reduced 95.14%	2,974 Ordinary Shares
Mar 07 2022	SELL Open market or private sale	$66,750 $7.37 p/Share	9,057 Reduced 12.9%	61,137 Ordinary Shares
Mar 05 2022	BUY Exercise of conversion of derivative security	-	20,199 Added 22.35%	70,194 Ordinary Shares
Mar 04 2022	SELL Open market or private sale	$173,940 $7.48 p/Share	23,254 Reduced 31.75%	49,995 Ordinary Shares
Mar 04 2022	BUY Exercise of conversion of derivative security	-	51,869 Added 47.98%	56,241 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$52,519 $8.14 p/Share	6,452 Reduced 23.18%	21,380 Ordinary Shares
Feb 28 2022	BUY Exercise of conversion of derivative security	-	18,430 Added 39.84%	27,832 Ordinary Shares
Feb 09 2022	SELL Open market or private sale	$55,357 $9.06 p/Share	6,110 Reduced 39.39%	9,402 Ordinary Shares
Feb 09 2022	BUY Exercise of conversion of derivative security	-	12,538 Added 44.7%	15,512 Ordinary Shares
May 11 2021	SELL Open market or private sale	$387,174 $10.22 p/Share	37,884 Reduced 92.72%	2,974 Ordinary Shares
May 11 2021	BUY Exercise of conversion of derivative security	-	37,884 Added 48.11%	40,858 Ordinary Shares
Mar 04 2021	SELL Open market or private sale	$147,240 $10.57 p/Share	13,930 Reduced 82.41%	2,974 Ordinary Shares
Mar 04 2021	BUY Exercise of conversion of derivative security	-	13,930 Added 45.18%	16,904 Ordinary Shares
Mar 01 2021	SELL Open market or private sale	$199,597 $10.83 p/Share	18,430 Reduced 86.11%	2,974 Ordinary Shares
Feb 28 2021	BUY Exercise of conversion of derivative security	-	18,430 Added 46.27%	21,404 Ordinary Shares
Feb 16 2021	SELL Open market or private sale	$43,657 $11.12 p/Share	3,926 Reduced 56.9%	2,974 Ordinary Shares
Feb 14 2021	BUY Exercise of conversion of derivative security	-	3,926 Added 36.26%	6,900 Ordinary Shares
Feb 09 2021	SELL Open market or private sale	$828,809 $12.69 p/Share	65,312 Reduced 95.64%	2,974 Ordinary Shares
Feb 09 2021	BUY Grant, award, or other acquisition	-	52,774 Added 43.59%	68,286 Ordinary Shares

DMS

David Matthew Stark

Exec. VP Chief Legal Officer

Tel Aviv, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Value

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA

Account